期刊文献+

气囊蛋白基脑胶质瘤靶向诊疗一体化载体构建及其评价 被引量:1

Synthesis and Evaluation of a Gas Vesicle-based Glioma Targeted Theragnostic Platform
在线阅读 下载PDF
导出
摘要 针对目前脑胶质瘤诊断治疗中靶向性差、治疗效率低等问题,设计合成以气囊蛋白(Gas vesicles,GV)为载体,透明质酸(Hyaluronic acid,HA)靶向负载阿霉素(Doxorubicin,DOX)的纳米药物递送系统。利用EDC/NHS脱水缩合反应,制备GV@hDOX载药系统,观察其对小鼠脑胶质瘤的杀伤作用以及超声成像效果。首先,通过化学反应将HA-DOX接枝在GV的表面,得到具有靶向作用的GV@hDOX;其次,通过透射电子显微镜和荧光光谱仪等仪器对GV和GV@hDOX的形貌结构进行表征;最后,对其体外稳定性、靶向肿瘤细胞吞噬与杀伤能力进行评价。透射电子显微镜和荧光光谱图表明GV@hDOX的成功合成,负载量为66.7μg/OD_(500);与GV相比,GV@hDOX具有更高的超声成像能力;与游离DOX相比,GV@hDOX显著提高了小鼠脑胶质瘤GL261细胞对DOX的吞噬效率。GV@hDOX优异的超声成像和药物递送效率为脑胶质瘤的靶向载药系统的构建提供了新的思路,为进一步实现脑胶质瘤的高效治疗奠定了基础。 The purpose of this study is to design and synthesize a new nanodrug delivery system overcoming bad targeting and low efficiency in the treatment of glioblastoma.Gas vesicles(GV)were used as carriers,hyaluronic acid(HA)served as targeting molecules,and doxorubicin(DOX)acted as the payload.The GV@hDOX drug delivery system was prepared using EDC/NHS dehydration condensation reaction,and its killing effect on mouse glioblastoma and ultrasound imaging were observed.Firstly,HA-DOX was grafted onto the surface of GV through a chemical reaction to obtain targeted GV@hDOX.Secondly,the morphology and structure of GV and GV@hDOX were characterized by transmission electron microscopy and fluorescence spectrophotometer.Finally,the in vitro stability,targeting tumor cell phagocytosis and killing ability were evaluated.GV@hDOX was successfully synthesized with a loading capacity of 66.7μg/OD_(500).Compared with GV,GV@hDOX had higher ultrasound imaging ability,and it significantly increased the phagocytic efficiency of DOX by mouse glioblastoma GL261 cells compared with free DOX.Therefore,GV@hDOX with excellent ultrasound imaging and drug delivery efficiency provides a new approach for the treatment of glioblastoma,and lays a foundation for further research in the future.
作者 崔雨童 韩佳铌 唐燕琼 马香 李宏 李娟娟 刘柱 CUI Yu-tong;HAN Jia-ni;TANG Yan-qiong;MA Xiang;LI Hong;LI Juan-juan;LIU Zhu(School of Life Sciences,Hainan University,Haikou 570208,China)
出处 《化学试剂》 CAS 北大核心 2023年第11期25-31,共7页 Chemical Reagents
基金 国家自然科学基金项目(32260020,32260028) 武汉光电国家研究中心开放基金项目(2020WNLOKF019)。
关键词 气囊蛋白 脑胶质瘤 阿霉素 载药系统 gas vesicle glioma cells doxorubicin drug delivery system
  • 相关文献

参考文献7

二级参考文献48

  • 1蔡照胜,孙岳明,朱雪梅.邻双胍基苯甲酸盐酸盐的合成研究[J].化学世界,2012,53(7):425-428. 被引量:4
  • 2Sneath RJ, Mangham DC. The normal structure and func-tion of CD44 and its role in neoplasia [J]. Mol Pathol.1998,51(4):191-200.
  • 3Afify A,Purnell P,Nguyen L, Role of CD44s and CD44v6on human breast cancer cell adhesion, migration, and inva-sion[J]. Exp Mol Pathol, 2009 ,86(2) :95-100.
  • 4Katoh S,Zheng Z,Oritani K,et al. Glycosylation of CD44negatively regulates its recognition of hyaluronan[J]. JExp Med,1995,182(2) :419-429.
  • 5Levesque MC, Haynes BF. In vitro culture of human pe-ripheral blood monocytes induces hyaluronan binding andup-regulates monocyte variant CD44 isoform expression[J]. J Immunol,1996,156(4) -1557-1565.
  • 6Tzircotis G,Thorne RF, Isacke CM. Chemotaxis towardshyaluronan is dependent on CD44 expression and modula-ted by cell type variation in CD44-hyaluronan binding[J].J Cell Sci,2005,118(21):5119-5128.
  • 7Platt VM,Szoka FC Jr. Anticancer therapeutics: targetingmacromolecules and nanocarriers to hyaluronan or CD44,a hyaluronan receptor [J]. Mol Pharm, 2008 ,5 (4): 474-486.
  • 8Li SD, Howell SB. CD44-targeted microparticles for deliv-ery of cisplatin to peritoneal metastases[J]. Mol Pharm,2009,7(1).280-290.
  • 9Marangoni E,Lecomte N,Durand L,et al. CD44 targetingreduces tumour growth and prevents post-chemotherapyrelapse of human breast cancers xenografts[J]. Br J Canc-er, 2009 ,100(6) : 918-922.
  • 10Choi KY, Yoon HY, Kim JH, et al. Smart nanocarrierbased on PEGylated hyaluronic acid for cancer therapy[J]. ACS Nano,2011,5(11) :8591-8599.

共引文献21

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部